SpliceBio
Sandra Motas Mallol, a highly experienced professional, currently holds the position of Director at SpliceBio. Prior to this role, Sandra worked as a Researcher/Project Leader in R&D Biologics at HIPRA. With a background in Biochemistry, Molecular Biology, and Biomedicine, Sandra completed their PhD at Universitat Autònoma de Barcelona, where Sandra also served as a PhD Researcher. Throughout their career, Sandra has gained experience in various research positions, including roles at CNIC and Centre de Genética Girona. Sandra's dedication to the field is evident through their voluntary work and apprenticeships in laboratories, showcasing their commitment to scientific advancement.
This person is not in any teams
SpliceBio
Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.